The Melbourne-based firm has confirmed the new appointment. SG Hiscock and Company has announced Giles Croker as its new chief executive officer and chief operating officer. Mr Croker will move into
Rory Hunter, portfolio manager, said Australian medical technology was among the best in the world and the fund would offer investors access to high quality growth companies.
“Australia s history of medical breakthroughs includes penicillin, the bionic ear, ultrasounds, spray-on skin, and the cervical cancer vaccine,” Hunter said.
“In addition, there are many research facilities in Australia which are recognised as medical centres of excellence at a global level.
“Investors will also benefit from several tailwinds that are driving innovation and growth in medical research and technology.”
The fund would be run by the SGH emerging companies team and guided by the SGH medical technology advisory board, which was comprised of: